Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Ready
Primary summary from verified readiness
- Confidence
- 79% · fresh
- Computed at
- 2026-10-21T06:32:35.168037+00:00
- Claimed
- 70
- Reported
- 68
- Verified
- 62
- Gap
- +8
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-10-21
Track; not yet
- Why
- An FDA 510(k) clearance is a hard regulatory milestone and, by its stated intended use, likely places NEXT-Cue in the product-code QWT category (21 CFR 882.1454) alongside Darmiyan's BrainSee (the release does not name the product code). The release discloses no accuracy figures, validation population, 510(k) number or predicate. No adoption evidence was found: the release only describes planned US real-world use cases.
- Next
- Pull the 510(k) summary from the FDA database once posted to read intended-use ages, predicate and performance data; watch for the first US institutional deployments and the Korean MFDS decision (commercialization targeted early 2027).
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 0
- Tier 2
- 5
- Tier 3
- 2
- Supports
- 2
- Contradicts
- 0
- Context
- 5
- Latest observed
- 2026-10-20
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-10-21 Initial recorded band: ready.